` VERO (Venus Concept Inc) vs S&P 500 Comparison - Alpha Spread

VERO
vs
S&P 500

Over the past 12 months, VERO has underperformed S&P 500, delivering a return of -87% compared to the S&P 500's +14% growth.

Stocks Performance
VERO vs S&P 500

Loading
VERO
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
VERO vs S&P 500

Loading
VERO
S&P 500
Difference
www.alphaspread.com

Performance By Year
VERO vs S&P 500

Loading
VERO
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Venus Concept Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Venus Concept Inc
Glance View

Market Cap
1.3m USD
Industry
Health Care

Venus Concept, Inc. develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related practice enhancement services. The company is headquartered in Toronto, Ontario and currently employs 407 full-time employees. The company went IPO on 2017-10-12. The company develops, commercializes, and sells minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Freedom, Venus Viva, Venus Freeze Plus, Venus Glow, Venus Bliss, Venus Epileve and Venus Viva MD. Its hair restoration division includes NeoGraft, an automated hair restoration system that facilitates the harvesting of follicles during a Follicular unit extraction (FUE) process and the ARTAS and ARTAS iX Robotic Hair Restoration Systems, which harvests follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. The firm operates in the United States, Canada, United Kingdom, Japan, South Korea, Mexico, Argentina, Colombia, Spain, France, Germany, Australia, China, Hong Kong, and Israel.

VERO Intrinsic Value
Not Available
Back to Top